PHIA Koninklijke Philips N.V.

Philips wins ‘Best in KLAS’ award for its Vendor-Agnostic Image Viewer Vue Motion

Philips wins ‘Best in KLAS’ award for its Vendor-Agnostic Image Viewer Vue Motion

February 11, 2021

  • Philips Vendor-Agnostic Image Viewer (Vue Motion) wins KLAS Research ‘Best in KLAS’ award in Universal Viewer (Imaging) segment
  • Philips Image Management software (Vue PACS) and Philips EMR (Tasy) also recognized as top performers in multiple markets
  • Philips AI-enabled enterprise informatics portfolio reinforces company’s commitment to enhancing remote clinical collaboration, enabling healthcare providers to advance digital health transformation

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its Vendor-Neutral Image Viewer (Vue Motion) has won KLAS Research’s 2021 Best in KLAS Universal Viewer (Imaging) award. This marks the fourth year in a row that Philips’ zero-footprint, enterprise-wide viewer has received recognition in KLAS Research’s customer review-driven awards program. This latest accolade demonstrates Philips’ commitment to optimizing workflows to enhance timely, efficient and coordinated document sharing, giving radiologists and physicians seamless, secure access to patients’ imaging reports across multiple facilities and health IT systems to help shorten the path to precise decisions and treatments. Philips’ Image Management software (Vue PACS) and Philips EMR (Tasy), which brings data together from the electronic medical record to the referring physician to help standardize and centralize processes for enhanced efficiency, also received recognition in this year’s ‘, being ranked top performers in several world markets.

The Philips Enterprise Viewer module eliminates the need to download software for medical data or image viewing. The viewer can be embedded in a HIS or EMR portal to enable authorized users across the enterprise to quickly and easily view patient data and images with a single log-in. The independent viewer can be integrated with other suppliers’ DICOM archives or XDS repositories to ensure that clinicians have access to current or prior imaging, video and waveforms studies and other patient data whenever and wherever needed.

KLAS Research’s Best in KLAS recognition in the software and services market segment is awarded for solutions that have the broadest operational and clinical impact on healthcare organizations.

“Each year, thousands of healthcare professionals across the globe take the time to share their voice with KLAS,” said Adam Gale, KLAS President. “They know that sharing their perspective helps vendors to improve and helps their peers make better decisions. These conversations are a constant reminder to me of how necessary accurate, honest, and impartial reporting is in the healthcare industry. The Best in KLAS report and the awards it contains set the standard of excellence for software and services firms. Vendors who win the title of ‘Best in KLAS’ should celebrate and remember that providers now accept only the best from their products and services. The ‘Best in KLAS’ award serves as a signal to provider and payer organizations that they should expect excellence from the winning vendors.”

“When it comes to Enterprise Imaging, healthcare organizations are looking for informatics partners to advance digital transformation with scalable solutions that enable secure data access, streamline workflows, and help drive greater quality care,” said Calum Cunningham, General Manager of Enterprise Diagnostic Informatics at Philips. “This recognition by KLAS Research underscores the effectiveness and value of our patient-centric strategy. With our advanced clinical and operational capabilities, enhanced by AI and analytics, we are able to partner with healthcare systems in a more meaningful way as we work toward one integrated workflow that brings data, technology and people together to deliver on the Quadruple Aim of improving patient outcomes, improving patient and staff experience, and lowering the cost of care.”

Philips’ quickly and securely delivers the right clinical images to authorized stakeholders – including clinicians, patients, payers and administrators – removing the barriers of technology, location and mobility in order to improve healthcare delivery, lower costs and provide a better patient experience in multiple settings.  For example, referring clinicians can use the system to show radiology images to their patients in the comfort of a doctor’s office or the patient’s home, helping to build the patient engagement and confidence that leads to better decision-making and therapy adherence.

Philips Picture Archiving and Communication System (Vue PACS) is a scalable and modular image management solution that provides hospitals and related institutions with scalable (local and wide area) PACS functionalities.

Philips’ Enterprise Imaging informatics portfolio supports hospitals and imaging centers as they seek to connect and optimize performance, improving the patient experience, health outcomes, and staff experience, while lowering the cost of care. Philips provides an industry-leading, end-to-end portfolio of enterprise informatics solutions that enables patients, clinicians and hospital administrators to fully harness the power of information and translate data into actionable insights – a critical next step to advance the healthcare enterprise.

Philips will be highlighting its award-winning solutions and enterprise imaging portfolio at the virtual event (March 3-7, 2021). For more information on Philips’ new portfolio of diagnostic and interventional solutions and AI-enabled applications to enhance radiology workflows at ECR 2021, visit the , and follow for updates throughout the event.

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail :

Twitter:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



Attachments



EN
11/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips intends to extend maturity of forward purchases of 4 million s...

Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans September 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this . For further information, please contact:Michael FuchsPhil...

 PRESS RELEASE

Philips and Masimo announce innovation partnership to advance access t...

Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies September 11, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and (NASDAQ: MASI) today announced that the two companies have renewed their multi-year strategic collaboration, marking a fresh chapter in their long-standing partnership. With a shared commitment to innovation and expanding access to high-quality, connected care, the two companies are taking a bold new approach in accelerating the development and delivery of next-...

 PRESS RELEASE

Philips launches smart telemetry platform for cardiac monitoring that ...

Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside September 4, 2025 Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move Cambridge, Massachusetts – , a global leader in health technology, today announced the introduction of an  designed to help address critical challenges in healthcare – including staff shortages and alarm management. A key component of the solution is the next-generation Telemetry M...

 PRESS RELEASE

Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, deliver...

Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound August 27, 2025  Next-generation 2D and 3D imaging and intelligent automation empower clinicians to make faster, more confident decisions in cardiac care Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the release of Transcend Plus, the next generation its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems. Transcend Plus delivers major advancements in image qua...

Marc Hesselink ... (+3)
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Philips/Volatile results/HOLD

Philips reported a better-than-expected 2Q25 update. We increase our target price to €23 per share (from €21) but keep our Hold rating. The results are surprisingly volatile in our view with large quarterly fluctuations. We believe valuation is fair relative to peers given its lower growth and margin profile.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch